Loading company…
Pharmacelera develops computational chemistry software for drug discovery.
Pharmacelera provides software including PharmScreen, exaScreen, and PharmQSAR to help identify compounds and optimize drug candidates. Its clients include biotech and pharmaceutical companies, research institutions, and CROs. Founded in 2015 in Barcelona by Enric Gibert (CEO), Javier Luque, and Enric Herrero, the company raised EUR 6 million in February 2026, led by HERAN Partners, with Clave Capital, Inveready Asset Management, and Bio&Tech Smart Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in